J&J Stock Dips After Healthcare Giant Posts Earnings

Johnson & Johnson (JNJ) raised its adjusted earnings outlook for the year after posting higher third-quarter revenue, despite a drop in sales of its Covid-19 vaccine.

J&J’s shares, down nearly 11% this year, fell more than 1% in afternoon trading.